Genmab A (GMAB) Change in Inventory (2023 - 2026)

Genmab A (GMAB) has reported Change in Inventory for 4 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Inventory rose 175.0% year-over-year to $3.0 million; the trailing twelve-month figure through Jun 2026 stood at -$9.0 million (up 10.0% YoY), and the FY2025 full-year result was -$9.0 million, down 800.0% from the prior year.
• Change in Inventory rose to $3.0 million in Q2 2026 per GMAB's latest filing, from -$3.0 million in the prior quarter.
• Across five years, Change in Inventory topped out at $3.0 million in Q2 2024 and bottomed at -$8.0 million in Q4 2023.
• Historically, Change in Inventory has averaged -$2.7 million across 4 years, with a median of -$3.0 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Change in Inventory slumped 233.33% in 2025, then jumped 175.0% in 2026.
• Over 4 years, Change in Inventory stood at -$8.0 million in 2023, then jumped by 87.5% to -$1.0 million in 2024, then slumped by 400.0% to -$5.0 million in 2025, then soared by 160.0% to $3.0 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered $3.0 million, -$3.0 million, and -$5.0 million for Q2 2026, Q1 2026, and Q3 2025 respectively.